Global Angiotensin Receptor Blockers (ARBs) Market Growth 2024-2031

Report ID: 1338541 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Angiotensin Receptor Blockers (ARBs) Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Angiotensin Receptor Blockers (ARBs) by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Angiotensin Receptor Blockers (ARBs) by Country/Region, 2017, 2022 & 2028
    2.2 Angiotensin Receptor Blockers (ARBs) Segment by Type
        2.2.1 Valsartan
        2.2.2 Telmisartan
        2.2.3 Losartan
        2.2.4 Irbesartan
        2.2.5 Azilsartan
        2.2.6 Olmesartan
    2.3 Angiotensin Receptor Blockers (ARBs) Sales by Type
        2.3.1 Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2017-2022)
        2.3.2 Global Angiotensin Receptor Blockers (ARBs) Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Angiotensin Receptor Blockers (ARBs) Sale Price by Type (2017-2022)
    2.4 Angiotensin Receptor Blockers (ARBs) Segment by Application
        2.4.1 Hypertension
        2.4.2 Cardiovascular Diseases
        2.4.3 Kidney Diseases
        2.4.4 Other
    2.5 Angiotensin Receptor Blockers (ARBs) Sales by Application
        2.5.1 Global Angiotensin Receptor Blockers (ARBs) Sale Market Share by Application (2017-2022)
        2.5.2 Global Angiotensin Receptor Blockers (ARBs) Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Angiotensin Receptor Blockers (ARBs) Sale Price by Application (2017-2022)
3 Global Angiotensin Receptor Blockers (ARBs) by Company
    3.1 Global Angiotensin Receptor Blockers (ARBs) Breakdown Data by Company
        3.1.1 Global Angiotensin Receptor Blockers (ARBs) Annual Sales by Company (2020-2022)
        3.1.2 Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Company (2020-2022)
    3.2 Global Angiotensin Receptor Blockers (ARBs) Annual Revenue by Company (2020-2022)
        3.2.1 Global Angiotensin Receptor Blockers (ARBs) Revenue by Company (2020-2022)
        3.2.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Company (2020-2022)
    3.3 Global Angiotensin Receptor Blockers (ARBs) Sale Price by Company
    3.4 Key Manufacturers Angiotensin Receptor Blockers (ARBs) Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Angiotensin Receptor Blockers (ARBs) Product Location Distribution
        3.4.2 Players Angiotensin Receptor Blockers (ARBs) Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Angiotensin Receptor Blockers (ARBs) by Geographic Region
    4.1 World Historic Angiotensin Receptor Blockers (ARBs) Market Size by Geographic Region (2017-2022)
        4.1.1 Global Angiotensin Receptor Blockers (ARBs) Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Angiotensin Receptor Blockers (ARBs) Annual Revenue by Geographic Region
    4.2 World Historic Angiotensin Receptor Blockers (ARBs) Market Size by Country/Region (2017-2022)
        4.2.1 Global Angiotensin Receptor Blockers (ARBs) Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Angiotensin Receptor Blockers (ARBs) Annual Revenue by Country/Region
    4.3 Americas Angiotensin Receptor Blockers (ARBs) Sales Growth
    4.4 APAC Angiotensin Receptor Blockers (ARBs) Sales Growth
    4.5 Europe Angiotensin Receptor Blockers (ARBs) Sales Growth
    4.6 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Growth
5 Americas
    5.1 Americas Angiotensin Receptor Blockers (ARBs) Sales by Country
        5.1.1 Americas Angiotensin Receptor Blockers (ARBs) Sales by Country (2017-2022)
        5.1.2 Americas Angiotensin Receptor Blockers (ARBs) Revenue by Country (2017-2022)
    5.2 Americas Angiotensin Receptor Blockers (ARBs) Sales by Type
    5.3 Americas Angiotensin Receptor Blockers (ARBs) Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Angiotensin Receptor Blockers (ARBs) Sales by Region
        6.1.1 APAC Angiotensin Receptor Blockers (ARBs) Sales by Region (2017-2022)
        6.1.2 APAC Angiotensin Receptor Blockers (ARBs) Revenue by Region (2017-2022)
    6.2 APAC Angiotensin Receptor Blockers (ARBs) Sales by Type
    6.3 APAC Angiotensin Receptor Blockers (ARBs) Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Angiotensin Receptor Blockers (ARBs) by Country
        7.1.1 Europe Angiotensin Receptor Blockers (ARBs) Sales by Country (2017-2022)
        7.1.2 Europe Angiotensin Receptor Blockers (ARBs) Revenue by Country (2017-2022)
    7.2 Europe Angiotensin Receptor Blockers (ARBs) Sales by Type
    7.3 Europe Angiotensin Receptor Blockers (ARBs) Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Angiotensin Receptor Blockers (ARBs) by Country
        8.1.1 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Revenue by Country (2017-2022)
    8.2 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales by Type
    8.3 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Angiotensin Receptor Blockers (ARBs)
    10.3 Manufacturing Process Analysis of Angiotensin Receptor Blockers (ARBs)
    10.4 Industry Chain Structure of Angiotensin Receptor Blockers (ARBs)
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Angiotensin Receptor Blockers (ARBs) Distributors
    11.3 Angiotensin Receptor Blockers (ARBs) Customer
12 World Forecast Review for Angiotensin Receptor Blockers (ARBs) by Geographic Region
    12.1 Global Angiotensin Receptor Blockers (ARBs) Market Size Forecast by Region
        12.1.1 Global Angiotensin Receptor Blockers (ARBs) Forecast by Region (2023-2028)
        12.1.2 Global Angiotensin Receptor Blockers (ARBs) Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Angiotensin Receptor Blockers (ARBs) Forecast by Type
    12.7 Global Angiotensin Receptor Blockers (ARBs) Forecast by Application
13 Key Players Analysis
    13.1 Pfizer
        13.1.1 Pfizer Company Information
        13.1.2 Pfizer Angiotensin Receptor Blockers (ARBs) Product Offered
        13.1.3 Pfizer Angiotensin Receptor Blockers (ARBs) Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Pfizer Main Business Overview
        13.1.5 Pfizer Latest Developments
    13.2 Novartis
        13.2.1 Novartis Company Information
        13.2.2 Novartis Angiotensin Receptor Blockers (ARBs) Product Offered
        13.2.3 Novartis Angiotensin Receptor Blockers (ARBs) Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Novartis Main Business Overview
        13.2.5 Novartis Latest Developments
    13.3 Merck
        13.3.1 Merck Company Information
        13.3.2 Merck Angiotensin Receptor Blockers (ARBs) Product Offered
        13.3.3 Merck Angiotensin Receptor Blockers (ARBs) Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Merck Main Business Overview
        13.3.5 Merck Latest Developments
    13.4 Astra Zeneca
        13.4.1 Astra Zeneca Company Information
        13.4.2 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Product Offered
        13.4.3 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Astra Zeneca Main Business Overview
        13.4.5 Astra Zeneca Latest Developments
    13.5 Jhonson and Johnson
        13.5.1 Jhonson and Johnson Company Information
        13.5.2 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Product Offered
        13.5.3 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Jhonson and Johnson Main Business Overview
        13.5.5 Jhonson and Johnson Latest Developments
    13.6 Eli Lilly
        13.6.1 Eli Lilly Company Information
        13.6.2 Eli Lilly Angiotensin Receptor Blockers (ARBs) Product Offered
        13.6.3 Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Eli Lilly Main Business Overview
        13.6.5 Eli Lilly Latest Developments
    13.7 Sanofi
        13.7.1 Sanofi Company Information
        13.7.2 Sanofi Angiotensin Receptor Blockers (ARBs) Product Offered
        13.7.3 Sanofi Angiotensin Receptor Blockers (ARBs) Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Sanofi Main Business Overview
        13.7.5 Sanofi Latest Developments
    13.8 Bristol-Myers Squibb
        13.8.1 Bristol-Myers Squibb Company Information
        13.8.2 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Product Offered
        13.8.3 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Bristol-Myers Squibb Main Business Overview
        13.8.5 Bristol-Myers Squibb Latest Developments
    13.9 Bayer
        13.9.1 Bayer Company Information
        13.9.2 Bayer Angiotensin Receptor Blockers (ARBs) Product Offered
        13.9.3 Bayer Angiotensin Receptor Blockers (ARBs) Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Bayer Main Business Overview
        13.9.5 Bayer Latest Developments
    13.10 GSK
        13.10.1 GSK Company Information
        13.10.2 GSK Angiotensin Receptor Blockers (ARBs) Product Offered
        13.10.3 GSK Angiotensin Receptor Blockers (ARBs) Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 GSK Main Business Overview
        13.10.5 GSK Latest Developments
    13.11 Teva Pharmaceutical
        13.11.1 Teva Pharmaceutical Company Information
        13.11.2 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Product Offered
        13.11.3 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Teva Pharmaceutical Main Business Overview
        13.11.5 Teva Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Angiotensin Receptor Blockers (ARBs) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Angiotensin Receptor Blockers (ARBs) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Valsartan
    Table 4. Major Players of Telmisartan
    Table 5. Major Players of Losartan
    Table 6. Major Players of Irbesartan
    Table 7. Major Players of Azilsartan
    Table 8. Major Players of Olmesartan
    Table 9. Global Angiotensin Receptor Blockers (ARBs) Sales by Type (2017-2022) & (K MT)
    Table 10. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2017-2022)
    Table 11. Global Angiotensin Receptor Blockers (ARBs) Revenue by Type (2017-2022) & ($ million)
    Table 12. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Type (2017-2022)
    Table 13. Global Angiotensin Receptor Blockers (ARBs) Sale Price by Type (2017-2022) & (USD/Unit)
    Table 14. Global Angiotensin Receptor Blockers (ARBs) Sales by Application (2017-2022) & (K MT)
    Table 15. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2017-2022)
    Table 16. Global Angiotensin Receptor Blockers (ARBs) Revenue by Application (2017-2022)
    Table 17. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Application (2017-2022)
    Table 18. Global Angiotensin Receptor Blockers (ARBs) Sale Price by Application (2017-2022) & (USD/Unit)
    Table 19. Global Angiotensin Receptor Blockers (ARBs) Sales by Company (2020-2022) & (K MT)
    Table 20. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Company (2020-2022)
    Table 21. Global Angiotensin Receptor Blockers (ARBs) Revenue by Company (2020-2022) ($ Millions)
    Table 22. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Company (2020-2022)
    Table 23. Global Angiotensin Receptor Blockers (ARBs) Sale Price by Company (2020-2022) & (USD/Unit)
    Table 24. Key Manufacturers Angiotensin Receptor Blockers (ARBs) Producing Area Distribution and Sales Area
    Table 25. Players Angiotensin Receptor Blockers (ARBs) Products Offered
    Table 26. Angiotensin Receptor Blockers (ARBs) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 27. New Products and Potential Entrants
    Table 28. Mergers & Acquisitions, Expansion
    Table 29. Global Angiotensin Receptor Blockers (ARBs) Sales by Geographic Region (2017-2022) & (K MT)
    Table 30. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share Geographic Region (2017-2022)
    Table 31. Global Angiotensin Receptor Blockers (ARBs) Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 32. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Geographic Region (2017-2022)
    Table 33. Global Angiotensin Receptor Blockers (ARBs) Sales by Country/Region (2017-2022) & (K MT)
    Table 34. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country/Region (2017-2022)
    Table 35. Global Angiotensin Receptor Blockers (ARBs) Revenue by Country/Region (2017-2022) & ($ millions)
    Table 36. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country/Region (2017-2022)
    Table 37. Americas Angiotensin Receptor Blockers (ARBs) Sales by Country (2017-2022) & (K MT)
    Table 38. Americas Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2017-2022)
    Table 39. Americas Angiotensin Receptor Blockers (ARBs) Revenue by Country (2017-2022) & ($ Millions)
    Table 40. Americas Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2017-2022)
    Table 41. Americas Angiotensin Receptor Blockers (ARBs) Sales by Type (2017-2022) & (K MT)
    Table 42. Americas Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2017-2022)
    Table 43. Americas Angiotensin Receptor Blockers (ARBs) Sales by Application (2017-2022) & (K MT)
    Table 44. Americas Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2017-2022)
    Table 45. APAC Angiotensin Receptor Blockers (ARBs) Sales by Region (2017-2022) & (K MT)
    Table 46. APAC Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region (2017-2022)
    Table 47. APAC Angiotensin Receptor Blockers (ARBs) Revenue by Region (2017-2022) & ($ Millions)
    Table 48. APAC Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region (2017-2022)
    Table 49. APAC Angiotensin Receptor Blockers (ARBs) Sales by Type (2017-2022) & (K MT)
    Table 50. APAC Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2017-2022)
    Table 51. APAC Angiotensin Receptor Blockers (ARBs) Sales by Application (2017-2022) & (K MT)
    Table 52. APAC Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2017-2022)
    Table 53. Europe Angiotensin Receptor Blockers (ARBs) Sales by Country (2017-2022) & (K MT)
    Table 54. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2017-2022)
    Table 55. Europe Angiotensin Receptor Blockers (ARBs) Revenue by Country (2017-2022) & ($ Millions)
    Table 56. Europe Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2017-2022)
    Table 57. Europe Angiotensin Receptor Blockers (ARBs) Sales by Type (2017-2022) & (K MT)
    Table 58. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2017-2022)
    Table 59. Europe Angiotensin Receptor Blockers (ARBs) Sales by Application (2017-2022) & (K MT)
    Table 60. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2017-2022)
    Table 61. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales by Country (2017-2022) & (K MT)
    Table 62. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2017-2022)
    Table 63. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Revenue by Country (2017-2022) & ($ Millions)
    Table 64. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2017-2022)
    Table 65. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales by Type (2017-2022) & (K MT)
    Table 66. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2017-2022)
    Table 67. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales by Application (2017-2022) & (K MT)
    Table 68. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2017-2022)
    Table 69. Key Market Drivers & Growth Opportunities of Angiotensin Receptor Blockers (ARBs)
    Table 70. Key Market Challenges & Risks of Angiotensin Receptor Blockers (ARBs)
    Table 71. Key Industry Trends of Angiotensin Receptor Blockers (ARBs)
    Table 72. Angiotensin Receptor Blockers (ARBs) Raw Material
    Table 73. Key Suppliers of Raw Materials
    Table 74. Angiotensin Receptor Blockers (ARBs) Distributors List
    Table 75. Angiotensin Receptor Blockers (ARBs) Customer List
    Table 76. Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Region (2023-2028) & (K MT)
    Table 77. Global Angiotensin Receptor Blockers (ARBs) Sales Market Forecast by Region
    Table 78. Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 79. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share Forecast by Region (2023-2028)
    Table 80. Americas Angiotensin Receptor Blockers (ARBs) Sales Forecast by Country (2023-2028) & (K MT)
    Table 81. Americas Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. APAC Angiotensin Receptor Blockers (ARBs) Sales Forecast by Region (2023-2028) & (K MT)
    Table 83. APAC Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 84. Europe Angiotensin Receptor Blockers (ARBs) Sales Forecast by Country (2023-2028) & (K MT)
    Table 85. Europe Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 86. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Forecast by Country (2023-2028) & (K MT)
    Table 87. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 88. Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Type (2023-2028) & (K MT)
    Table 89. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share Forecast by Type (2023-2028)
    Table 90. Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 91. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share Forecast by Type (2023-2028)
    Table 92. Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Application (2023-2028) & (K MT)
    Table 93. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share Forecast by Application (2023-2028)
    Table 94. Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 95. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share Forecast by Application (2023-2028)
    Table 96. Pfizer Basic Information, Angiotensin Receptor Blockers (ARBs) Manufacturing Base, Sales Area and Its Competitors
    Table 97. Pfizer Angiotensin Receptor Blockers (ARBs) Product Offered
    Table 98. Pfizer Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 99. Pfizer Main Business
    Table 100. Pfizer Latest Developments
    Table 101. Novartis Basic Information, Angiotensin Receptor Blockers (ARBs) Manufacturing Base, Sales Area and Its Competitors
    Table 102. Novartis Angiotensin Receptor Blockers (ARBs) Product Offered
    Table 103. Novartis Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 104. Novartis Main Business
    Table 105. Novartis Latest Developments
    Table 106. Merck Basic Information, Angiotensin Receptor Blockers (ARBs) Manufacturing Base, Sales Area and Its Competitors
    Table 107. Merck Angiotensin Receptor Blockers (ARBs) Product Offered
    Table 108. Merck Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 109. Merck Main Business
    Table 110. Merck Latest Developments
    Table 111. Astra Zeneca Basic Information, Angiotensin Receptor Blockers (ARBs) Manufacturing Base, Sales Area and Its Competitors
    Table 112. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Product Offered
    Table 113. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 114. Astra Zeneca Main Business
    Table 115. Astra Zeneca Latest Developments
    Table 116. Jhonson and Johnson Basic Information, Angiotensin Receptor Blockers (ARBs) Manufacturing Base, Sales Area and Its Competitors
    Table 117. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Product Offered
    Table 118. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 119. Jhonson and Johnson Main Business
    Table 120. Jhonson and Johnson Latest Developments
    Table 121. Eli Lilly Basic Information, Angiotensin Receptor Blockers (ARBs) Manufacturing Base, Sales Area and Its Competitors
    Table 122. Eli Lilly Angiotensin Receptor Blockers (ARBs) Product Offered
    Table 123. Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 124. Eli Lilly Main Business
    Table 125. Eli Lilly Latest Developments
    Table 126. Sanofi Basic Information, Angiotensin Receptor Blockers (ARBs) Manufacturing Base, Sales Area and Its Competitors
    Table 127. Sanofi Angiotensin Receptor Blockers (ARBs) Product Offered
    Table 128. Sanofi Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 129. Sanofi Main Business
    Table 130. Sanofi Latest Developments
    Table 131. Bristol-Myers Squibb Basic Information, Angiotensin Receptor Blockers (ARBs) Manufacturing Base, Sales Area and Its Competitors
    Table 132. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Product Offered
    Table 133. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 134. Bristol-Myers Squibb Main Business
    Table 135. Bristol-Myers Squibb Latest Developments
    Table 136. Bayer Basic Information, Angiotensin Receptor Blockers (ARBs) Manufacturing Base, Sales Area and Its Competitors
    Table 137. Bayer Angiotensin Receptor Blockers (ARBs) Product Offered
    Table 138. Bayer Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 139. Bayer Main Business
    Table 140. Bayer Latest Developments
    Table 141. GSK Basic Information, Angiotensin Receptor Blockers (ARBs) Manufacturing Base, Sales Area and Its Competitors
    Table 142. GSK Angiotensin Receptor Blockers (ARBs) Product Offered
    Table 143. GSK Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 144. GSK Main Business
    Table 145. GSK Latest Developments
    Table 146. Teva Pharmaceutical Basic Information, Angiotensin Receptor Blockers (ARBs) Manufacturing Base, Sales Area and Its Competitors
    Table 147. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Product Offered
    Table 148. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 149. Teva Pharmaceutical Main Business
    Table 150. Teva Pharmaceutical Latest Developments
List of Figures
    Figure 1. Picture of Angiotensin Receptor Blockers (ARBs)
    Figure 2. Angiotensin Receptor Blockers (ARBs) Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Angiotensin Receptor Blockers (ARBs) Sales Growth Rate 2017-2028 (K MT)
    Figure 7. Global Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Angiotensin Receptor Blockers (ARBs) Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Valsartan
    Figure 10. Product Picture of Telmisartan
    Figure 11. Product Picture of Losartan
    Figure 12. Product Picture of Irbesartan
    Figure 13. Product Picture of Azilsartan
    Figure 14. Product Picture of Olmesartan
    Figure 15. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type in 2021
    Figure 16. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Type (2017-2022)
    Figure 17. Angiotensin Receptor Blockers (ARBs) Consumed in Hypertension
    Figure 18. Global Angiotensin Receptor Blockers (ARBs) Market: Hypertension (2017-2022) & (K MT)
    Figure 19. Angiotensin Receptor Blockers (ARBs) Consumed in Cardiovascular Diseases
    Figure 20. Global Angiotensin Receptor Blockers (ARBs) Market: Cardiovascular Diseases (2017-2022) & (K MT)
    Figure 21. Angiotensin Receptor Blockers (ARBs) Consumed in Kidney Diseases
    Figure 22. Global Angiotensin Receptor Blockers (ARBs) Market: Kidney Diseases (2017-2022) & (K MT)
    Figure 23. Angiotensin Receptor Blockers (ARBs) Consumed in Other
    Figure 24. Global Angiotensin Receptor Blockers (ARBs) Market: Other (2017-2022) & (K MT)
    Figure 25. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2017-2022)
    Figure 26. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Application in 2021
    Figure 27. Angiotensin Receptor Blockers (ARBs) Revenue Market by Company in 2021 ($ Million)
    Figure 28. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Company in 2021
    Figure 29. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Geographic Region (2017-2022)
    Figure 30. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Geographic Region in 2021
    Figure 31. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region (2017-2022)
    Figure 32. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country/Region in 2021
    Figure 33. Americas Angiotensin Receptor Blockers (ARBs) Sales 2017-2022 (K MT)
    Figure 34. Americas Angiotensin Receptor Blockers (ARBs) Revenue 2017-2022 ($ Millions)
    Figure 35. APAC Angiotensin Receptor Blockers (ARBs) Sales 2017-2022 (K MT)
    Figure 36. APAC Angiotensin Receptor Blockers (ARBs) Revenue 2017-2022 ($ Millions)
    Figure 37. Europe Angiotensin Receptor Blockers (ARBs) Sales 2017-2022 (K MT)
    Figure 38. Europe Angiotensin Receptor Blockers (ARBs) Revenue 2017-2022 ($ Millions)
    Figure 39. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales 2017-2022 (K MT)
    Figure 40. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Revenue 2017-2022 ($ Millions)
    Figure 41. Americas Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country in 2021
    Figure 42. Americas Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country in 2021
    Figure 43. United States Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Canada Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 45. Mexico Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Brazil Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 47. APAC Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region in 2021
    Figure 48. APAC Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Regions in 2021
    Figure 49. China Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Japan Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 51. South Korea Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Southeast Asia Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 53. India Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Australia Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country in 2021
    Figure 56. Europe Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country in 2021
    Figure 57. Germany Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 58. France Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 59. UK Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Italy Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Russia Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country in 2021
    Figure 63. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country in 2021
    Figure 64. Egypt Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 65. South Africa Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 66. Israel Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 67. Turkey Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 68. GCC Country Angiotensin Receptor Blockers (ARBs) Revenue Growth 2017-2022 ($ Millions)
    Figure 69. Manufacturing Cost Structure Analysis of Angiotensin Receptor Blockers (ARBs) in 2021
    Figure 70. Manufacturing Process Analysis of Angiotensin Receptor Blockers (ARBs)
    Figure 71. Industry Chain Structure of Angiotensin Receptor Blockers (ARBs)
    Figure 72. Channels of Distribution
    Figure 73. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Angiotensin Receptor Blockers Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Angiotensin Receptor Blockers Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Angiotensin Receptor Blockers Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports